MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Do-not-resuscitate utilization in inpatient Parkinson’s disease in the United States

A. Mahajan, A. Patel, G. Nadkarni, C. Sidiropoulos (Detroit, MI, USA)

Meeting: 2016 International Congress

Abstract Number: 499

Keywords: Parkinsonism

Session Information

Date: Monday, June 20, 2016

Session Title: Quality of life/caregiver burden in movement disorders

Session Time: 12:30pm-2:00pm

Location: Exhibit Hall located in Hall B, Level 2

Objective: To investigate Do-not-resuscitate (DNR) order utilization in Parkinson’s disease (PD) hospitalizations patients in the United States.

Background: DNR order utilization in PD has been recognized to be as much an emphasis on quality of life, as it is on perception of imminent end of life. While DNR utilization is a complex phenomenon due to the subjectivity and individuality associated with the decision, the effect of such a decision can collectively influence attitudes of care and have a ripple effect beyond the individual patient level.

Methods: We reviewed the Healthcare Cost and Utilization Project’s National Inpatient Sample (NIS) database from 2012 for all hospitalizations >=65 years. We identified PD by using ICD-9-CM code 332.0 and DNR status with ICD code – V49.86 entered during the same admission as a secondary diagnosis. We estimated risk of mortality by the 3M™ All Patient Refined DRG (APR DRG) classification System and generated multivariate regression models to assess associations between DNR and PD after adjusting for confounders. Finally, we tested for interaction by risk of mortality.

Results: We analyzed 12,700,000 hospitalizations with age>=65 years in 2012, of which 246625 (1.94%) pts had PD. Overall, DNR utilization was seen in 743985 (5.9%) patients. Proportion of DNR utilization was higher among PD patients vs. those without, 20895 (8.47%) vs. 723090 (5.8%) (P: < 0.01). In multivariable regression analysis, PD patients were associated with higher odds of DNR utilization [Adjusted Odds ratio (aOR): 1.26, 95% CI: 1.21, 1.30, P < 0.001] after adjusting for patient level, hospital level characteristics and risk of mortality. Finally, the odds of DNR utilization increased significantly with APR-DRG stage [aOR: 1 vs 1.61(Stage 2) vs 2.46 (Stage 3) vs 3.61 S(Stage 4); p<0.0001].

Conclusions: PD patients have higher odds of DNR utilization than the general population, which worsens with increasing objective risk of mortality. This is likely correlated with perception of end of life and importance of QOL with increasing severity of overall illness. Further objective exploration of the factors leading to this decision can help us provide better care. *Abhimanyu and Achint have contributed equally. Christos and Girish have contributed equally.

To cite this abstract in AMA style:

A. Mahajan, A. Patel, G. Nadkarni, C. Sidiropoulos. Do-not-resuscitate utilization in inpatient Parkinson’s disease in the United States [abstract]. Mov Disord. 2016; 31 (suppl 2). https://www.mdsabstracts.org/abstract/do-not-resuscitate-utilization-in-inpatient-parkinsons-disease-in-the-united-states/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/do-not-resuscitate-utilization-in-inpatient-parkinsons-disease-in-the-united-states/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley